Program coordinator
Assc. prof. Marwa Atef
Mission of the Pharm D Program
The Faculty of Pharmacy, Pharos University in Alexandria, is committed to preparing competent
pharmacists and researchers who adhere to the ethics of professional practice at an effective and competitive level. Graduates are qualified to work in the fields of pharmaceutical care, drug
manufacturing, and community service within the framework of academic reference standards,
societal values, and technological advancement. This is achieved through a distinguished program that meets the demands of the labor market and contributes to achieving the Sustainable Development Goals in pharmaceutical education.
Pharm D Study Program
Pharm D – (New Bylaw 2019) – First Year – Semester 1
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPD 101 | Pharmacy Orientation | 1 | 1 | 0 | 0 | 1 | – |
| PPD 102 | Medical Terminology | 1 | 1 | 0 | 0 | 1 | – |
| PCD 101 | Pharmaceutical Analytical Chemistry I | 3 | 2 | 1 | 2 | 5 | – |
| PCD 102 | Pharmaceutical Organic Chemistry I | 3 | 2 | 1 | 2 | 5 | – |
| PCD 103 | Mathematics | 1 | 1 | 1 | 0 | 2 | – |
| PCD 104 | Information Technology I | 2 | 1 | 0 | 2 | 3 | – |
| PGD 101 | Human Rights and Fighting Corruption | 1 | 1 | 0 | 0 | 1 | – |
| PLD 101 | Cell Biology | 2 | 2 | 1 | 0 | 3 | – |
| UGA 03 | Arabic Language Skills | 2 | 2 | 0 | 0 | 2 | – |
| UGE 01 | English (1) | 2 | 0 | 2 | 2 | 4 | – |
| Total Semester | 18 | 13 | 6 | 8 | 27 |
Pharm D – (New Bylaw 2019) – First Year – Semester 2
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPD 103 | Physical Pharmacy | 3 | 2 | 0 | 2 | 4 | – |
| PCD 105 | Pharmaceutical AnalyticaI Chemistry Il | 3 | 2 | 1 | 2 | 5 | PCD 101 |
| PCD 106 | Pharmaceutical Organic Chemistry II | 3 | 2 | 1 | 2 | 5 | PCD 102 |
| PGD 102 | Medicinal Plants | 3 | 2 | 1 | 2 | 5 | – |
| PLD 102 | Anatomy and Histology | 3 | 2 | 0 | 2 | 4 | – |
| PLD 103 | Psychology | 1 | 1 | 1 | 0 | 2 | – |
| UGE 02 | (2) English | 2 | 0 | 2 | 2 | 4 | UGE 01 |
| Total Semester | 18 | 11 | 6 | 12 | 29 |
Pharm D – (New Bylaw 2019) – Second Year – Semester 3
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPD 201 | Pharmaceutics I | 3 | 2 | 0 | 2 | 4 | PPD 103 |
| PPD 203 | Communication Skills I | 1 | 1 | 1 | 0 | 2 | – |
| PCD 201 | Pharmaceutical AnalyticaI Chemistry IIl | 2 | 1 | 1 | 2 | 4 | PCD 105 |
| PCD 202 | Pharmaceutical Organic Chemistry IIl | 3 | 2 | 1 | 2 | 5 | PCD 106 |
| PGD 201 | Pharmacognosy I | 3 | 2 | 1 | 2 | 5 | PGD 102 |
| PMD 201 | General Microbiology and Immunology | 3 | 2 | 0 | 2 | 4 | PLD 101 |
| PLD 201 | Physiology and Pathophysiology | 3 | 2 | 1 | 2 | 5 | PLD 101 |
| Total Semester | 18 | 12 | 5 | 12 | 29 |
Pharm D – (New Bylaw 2019) – Second Year – Semester 4
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPD 202 | Pharmaceutics II | 3 | 2 | 0 | 2 | 4 | PPD 103 |
| PCD 203 | Instrumental Analysis | 3 | 2 | 1 | 2 | 5 | PCD 105 |
| PCD 204 | Electroanalytical Methods | 1 | 1 | 1 | 0 | 2 | PCD 201 |
| PGD 202 | Pharmacognosy II | 3 | 2 | 1 | 2 | 5 | PGD 102 |
| PMD 202 | Parasitology and Virology | 2 | 1 | 0 | 2 | 3 | PMD 201 |
| PLD 202 | Pathology | 2 | 2 | 1 | 0 | 3 | PLD 102 |
| PLD 203 | Biochemistry I | 3 | 2 | 0 | 2 | 4 | PCD 102 |
| PND 201 | Biostatistics | 2 | 1 | 0 | 2 | 3 | PCD 103 |
| Total Semester | 19 | 13 | 4 | 12 | 29 |
Pharm D – (New Bylaw 2019) – Third Year – Semester 5
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPD 301 | Pharmaceutics III | 3 | 2 | 0 | 2 | 4 | PPD 103 |
| PCD 301 | Medicinal Chemistry I | 3 | 2 | 1 | 2 | 5 | PCD 106 PCD 203 |
| PGD 301 | Phytochemistry I | 3 | 2 | 1 | 2 | 5 | PGD 202 |
| PMD 301 | Pharmaceutical Microbiology | 3 | 2 | 0 | 2 | 4 | PMD 201 |
| PLD 301 | Biochemistry II | 3 | 2 | 0 | 2 | 4 | PLD 203 |
| PLD 302 | Pharmacology I | 3 | 2 | 0 | 2 | 4 | PLD 201 |
| Total Semester | 18 | 12 | 2 | 12 | 26 |
Pharm D – (New Bylaw 2019) – Third Year – Semester 6
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPD 302 | Biopharmaceutics and Pharmacokinetics | 3 | 2 | 0 | 2 | 4 | PPD 201 PPD 301 |
| PPD 303 | Pharmaceutics IV | 3 | 2 | 0 | 2 | 4 | PPD 201 |
| PCD 302 | Medicinal Chemistry II | 3 | 2 | 1 | 2 | 5 | PCD 106 PLD 302 PCD 203 |
| PGD 302 | Phytochemistry II | 3 | 2 | 1 | 2 | 5 | PGD 202 |
| PMD 302 | Medical Microbiology | 3 | 2 | 0 | 2 | 4 | PMD 201 |
| PLD 303 | Pharmacology II | 3 | 2 | 0 | 2 | 4 | PLD 302 |
| Total Semester | 18 | 12 | 2 | 12 | 26 |
Pharm D – (New Bylaw 2019) – Fourth Year – Semester 7
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPD 401 | Pharmaceutical Technology I | 3 | 2 | 0 | 2 | 4 | PPD 201 PPD 202 PPD 301 |
| PGD 401 | Applied and Forensic Pharmacognosy | 2 | 1 | 0 | 2 | 3 | PGD 302 |
| PMD 401 | Public Health | 2 | 2 | 1 | 0 | 3 | PMD 301 |
| PLD 401 | Pharmacology III | 2 | 2 | 1 | 0 | 3 | PLD 303 |
| PLD 402 | Clinical Biochemistry | 3 | 2 | 0 | 2 | 4 | PLD 301 |
| PND 401 | Drug Information | 2 | 1 | 0 | 2 | 3 | – |
| PND 402 | Pharmaceutical Legislations and Regulatory Affairs | 1 | 1 | 0 | 0 | 1 | – |
| PMD 402 | (3) English | 2 | 0 | 2 | 2 | 4 | UGE 02 |
| E 01 | Elective 1 | 2 | 1 | 2 | 0 | 3 | – |
| Total Semester | 19 | 12 | 6 | 10 | 28 |
Pharm D – (New Bylaw 2019) – Fourth Year – Semester 8
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPD 402 | Pharmaceutical Technology II | 2 | 2 | 1 | 0 | 3 | PPD 401 |
| PCD 401 | Drug Design | 2 | 1 | 1 | 2 | 4 | PCD 301 |
| PLD 403 | Toxicology and Forensic chemistry | 3 | 2 | 0 | 2 | 4 | PLD 302 |
| PND 403 | Clinical Pharmacokinetics | 3 | 2 | 0 | 2 | 4 | PPD 302 |
| PND 404 | Hospital Pharmacy | 2 | 2 | 1 | 0 | 3 | PPD 303 PLD 303 |
| PND 405 | Community Pharmacy Practice | 3 | 2 | 0 | 2 | 4 | PPD 202 PPD 301 PLD 303 |
| PCD 402 | Information Technology II | 2 | 1 | 0 | 2 | 3 | PCD 104 |
| E 02 | Elective 2 | 2 | 1 | 2 | 0 | 3 | – |
| Total Semester | 19 | 13 | 5 | 10 | 28 |
Pharm D – (New Bylaw 2019) – Fifth Year – Semester 9
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPD 501 | Good Manufacturing Practice | 2 | 1 | 0 | 2 | 3 | PPD 402 |
| PCD 501 | Analytical Quality Control of Pharmaceuticals | 3 | 2 | 1 | 2 | 5 | PCD 203 |
| PGD 501 | Phytotherapy and Aromatherapy | 3 | 2 | 0 | 2 | 4 | PGD 302 |
| PMD 501 | Biotechnology | 2 | 2 | 1 | 0 | 3 | PMD 301 |
| PMD 502 | Clinical Research, Pharmacoepidemiology and pharmacovigilance | 2 | 1 | 2 | 0 | 3 | PND 202 PND 405 |
| PND 501 | Clinical pharmacy I | 3 | 2 | 0 | 2 | 4 | PND 404 |
| PPD 502 | Communication Skills II | 1 | 1 | 1 | 0 | 2 | PPD 203 |
| E 03 | Elective 3 | 2 | 1 | 2 | 0 | 3 | – |
| Total Semester | 18 | 12 | 7 | 8 | 27 |
Pharm D – (New Bylaw 2019) – Fifth Year – Semester 10
| Course code | Course title | CrH | L | T | P | CH | Pre-requisites |
| PPD 503 | Advanced Drug Delivery Systems | 2 | 2 | 0 | 0 | 2 | PPD 202 PPD 301 PPD 303 |
| PLD 501 | Drug interaction | 2 | 2 | 1 | 0 | 3 | PLD 401 |
| PLD 502 | First Aid | 1 | 1 | 1 | 0 | 2 | PLD 302 |
| PND 502 | Marketing and Pharmacoeconomics | 2 | 2 | 0 | 0 | 2 | PND 404 PMD 502 |
| PND 503 | Clinical Pharmacy II and pharmacotherpaeutics | 3 | 2 | 0 | 2 | 4 | PLD 401 PND 501 |
| PND 504 | Professional Ethics | 1 | 1 | 0 | 0 | 1 | – |
| PND 505 | Entrepreneurship | 1 | 1 | 1 | 0 | 2 | – |
| PND 506 | Scientific Writing | 2 | 1 | 0 | 2 | 3 | – |
| E 04 | Elective 4 | 2 | 1 | 2 | 0 | 3 | – |
| Total Semester | 16 | 13 | 5 | 4 | 22 |
Clinical Pharmacy & Pharmacy Practice Department (PN)
| No. | Course | Title | CrH | L | T | P | CH | Pr | ||||||
| Code | ||||||||||||||
| 1 | PND E01 | Management of chronic illness | 2 | 1 | 2 | 0 | 3 | PND 501 PLD 303 | ||||||
| 2 | PND E02 | Management of Critical Care Patients | 2 | 1 | 2 | 0 | 3 | PND 501 PLD 303 | ||||||
Microbiology and Immunology Department (PM)
| No. | Course | Title | CrH | L | T | P | CH | Pr | ||||||
| Code | ||||||||||||||
| 1 | PMD E01 | Environment and sustainability | 2 | 1 | 2 | 0 | 3 | PMD 201 | ||||||
| 2 | PMD E02 | Gene Regulation and Epigenetics. | 2 | 1 | 2 | 0 | 3 | PMD 201 | ||||||
| 3 | PMD E03 | Clinical immunology | 2 | 1 | 2 | 0 | 3 | PMD 201 | ||||||
| 4 | PMD E04 | Mycology | 2 | 1 | 2 | 0 | 3 | PMD 201 | ||||||
| 5 | PMD E05 | Bioinformatics. | 2 | 1 | 2 | 0 | 3 | PMD 201 | ||||||
| 6 | PMD E06 | Advanced microbiological techniques | 2 | 1 | 2 | 0 | 3 | PMD 302 | ||||||
| 7 | PMD E07 | Infection control | 2 | 1 | 2 | 0 | 3 | PMD 302 | ||||||
Pharmaceutical Chemistry Department (PC)
| No. | Course | Title | CrH | L | T | P | CH | Pr | ||||||
| Code | ||||||||||||||
| 1 | PCD E01 | hromatography and Separation Techniques | 2 | 1 | 2 | 0 | 3 | PCD 203 | ||||||
| 2 | PCD E02 | Analysis of food and flavours. | 2 | 1 | 2 | 0 | 3 | PCD 203 | ||||||
| 3 | PCD E03 | Forensic analysis | 2 | 1 | 2 | 0 | 3 | PGD 401 PCD 203 | ||||||
Pharmaceutics and Pharmaceutical Technology Department (PP)
| No. | Course | Title | CrH | L | T | P | CH | Pr | ||||||
| Code | ||||||||||||||
| 1 | PPD E01 | Cosmetics Preparations | 2 | 1 | 2 | 0 | 3 | PPD 201 PPD 202 PPD 301 | ||||||
| 2 | PPD E02 | Pharmaceutical Nanotechnology | 2 | 1 | 2 | 0 | 3 | PPD 402 | ||||||
| 3 | PPD E03 | Supply Chain Management | 2 | 1 | 2 | 0 | 3 | – | ||||||
Pharmacognosy and Natural products Department (PG)
| No. | Course | Title | CrH | L | T | P | CH | Pr | ||||||
| Code | ||||||||||||||
| 1 | PGD E01 | Natural Cosmetics | 2 | 1 | 2 | 0 | 3 | – | ||||||
| 2 | PGD E02 | Herbal medicine. | 2 | 1 | 2 | 0 | 3 | – | ||||||
Pharmacology and Therapeutics Department (PL)
| No. | Course | Title | CrH | L | T | P | CH | Pr | ||||||
| Code | ||||||||||||||
| 1 | PLD E01 | Pharmacotherapeutics for Special Population | 2 | 1 | 2 | 0 | 3 | PLD 303 PLD 401 | ||||||
| 2 | PLD E03 | Sustainability in Therapeutics | 2 | 1 | 2 | 0 | 3 | PLD 303 PLD 401 | ||||||
| 3 | PLD E02 | Addiction and Drug Abuse | 2 | 1 | 2 | 0 | 3 | PLD 403 | ||||||
| 4 | PLD E04 | Molecular Therapeutics | 2 | 1 | 2 | 0 | 3 | PLD 402 | ||||||
| 5 | PLD E05 | Complementary and Alternative Medicine | 2 | 1 | 2 | 0 | 3 | PLD 302 | ||||||
| Old System | ||
| Study Plane : PUA | ||
| Grade | MinimumScore | MaximumScore |
| A | 90 | 100 |
| A- | 85 | 89.5 |
| B+ | 80 | 84.5 |
| B | 75 | 79.5 |
| B- | 70 | 74.5 |
| C+ | 65 | 69.5 |
| C | 60 | 64.5 |
| C- | 56 | 59.5 |
| D+ | 53 | 55.5 |
| D | 50 | 52.5 |
| Power Campus | ||
| Curriculum ( Pharm D ,PharmD (Clinical)) | ||
| Grade | MinimumScore | MaximumScore |
| A+ | 97 | 100 |
| A | 90 | 96.5 |
| A- | 85 | 89.5 |
| B+ | 80 | 84.5 |
| B | 75 | 79.5 |
| C+ | 70 | 74.5 |
| C | 65 | 69.5 |
| D | 60 | 64.5 |